Crucell corporate brochure (PDF)

Crucell’s commitment to the world – Taking responsibility
Bringing color to children’s lives
Crucell employees gave generously to good causes in 2010. Here are
two examples we particularly like.
y Child ambassadors for Stichting Kinderpostzegels
(Foundation for Childrens’ Stamps) sold a record number of
stamps and cards during a lunchtime visit to Crucell’s Dutch
site in October 2010, raising over €1,400 from employees.
Crucell management doubled their contribution.
y Employees in Switzerland donated money to purchase over 200
coloring sets for the children in Bangladesh. The initiative was sparked
by a presentation on Friendship during a general staff meeting.
Access to healthcare
Crucell’s work with Friendship is an example of a targeted community
initiative to remove barriers to healthcare access. Crucell also works
on this issue at the international and global level, through close and
continuous engagement with a wide range of organizations. Here are
the 2010 highlights.
Crucell supported the International Pediatric Association (IPA) in its
efforts to drive EPI development by empowering its members to take
on an advocacy role. The IPA believes that pediatricians have a crucial
role to play in advising their governments on the best vaccines and
implementation strategies. Crucell gave the IPA an unrestricted grant
to run an advocacy workshop during its latest international congress,
held early August in Johannesburg, South Africa. Crucell also provided
a follow-up grant to help in-country implementation of the best
advocacy proposals.
At the same conference, Crucell supported educational activities
through the IPA. These focused on innovative strategies for simplifying
vaccine delivery, which are seen to be key for reaching neglected
populations. Crucell’s collaboration with the nonprofit organization
PATH to make Quinvaxem® available in a Uniject device underlines
our commitment to this type of innovation (see page 44).
In November 2010, the launch of a global Coalition Against Typhoid
(CaT) was announced by the Sabin Vaccine Institute in Washington,
DC, which will serve as the secretariat. Crucell played a significant role
in bringing together this worldwide collaboration of stakeholders in
the field of typhoid fever. “Despite the availability of low-cost vaccines
against typhoid and a WHO Strategic Advisory Group of Experts
recommendation for their use, typhoid fever vaccination has been a
low priority for many countries, including those most impacted by the
disease,” said Dr Christopher Nelson, Director of the CaT secretariat.
67